HLA mismatch is important for 20-year graft survival in kidney transplant patients

Transpl Immunol. 2023 Oct:80:101861. doi: 10.1016/j.trim.2023.101861. Epub 2023 Jun 10.

Abstract

Background: Human leukocyte antigens (HLA) matching is gradually being omitted from clinical practice in evaluation for renal allograft transplant. While such practices may yield shorter wait times and adequate short-term outcomes, graft longevity in HLA mismatched patients remains unclear. This study aims to demonstrate that HLA matching may still play an important role in long-term graft survival.

Methods: We identified patients undergoing an index kidney transplant in the United Network for Organ Sharing (UNOS) data from 1990 to 1999, with one-year graft survival. The primary outcome of the analysis was graft survival beyond 10 years. We explored the long-lasting impact of HLA mismatches by landmarking the analysis at established time points.

Results: We identified 76,530 patients receiving renal transplants in the time frame, 23,914 from living donors and 52,616 from deceased donors. On multivariate analysis, more HLA mismatches were associated with worse graft survival beyond 10 years for both living and deceased donor allografts. HLA mismatch continued to remain an essential factor in the long term.

Conclusions: A greater number of HLA mismatches was associated with progressively worse long-term graft survival for patients. Our analysis reinforces the importance of HLA matching in the preoperative evaluation of renal allografts.

Keywords: Graft survival; HLA mismatch; Kidney transplant.

MeSH terms

  • Graft Rejection
  • Graft Survival
  • HLA Antigens
  • Histocompatibility Testing
  • Humans
  • Kidney
  • Kidney Transplantation* / adverse effects
  • Living Donors
  • Tissue Donors

Substances

  • HLA Antigens